This observational study reviewed the association between daily haemodialysis and transplantation and survival in France. The likelihood of undergoing transplantation after being waitlisted was lower for patients on daily haemodialysis compared to thriceweekly haemodialysis. Additionally, daily haemodialysis was associated with higher risk of death, even after taking into account age and co-morbidities.
New dialysis regimens have been developed and tested with the aim of improving the patients' quality of life 1, 2 and blood purification. 3, 4 For instance, some authors have shown that increasing the weekly frequency of dialysis sessions is the best regimen to mimic the kidney functional role, compared with haemodialysis (HD) three times/week. 3, [5] [6] [7] Several studies on daily haemodialysis (DHD) reported the positive effects of increasing the number of HD sessions per week on the control of blood pressure, 4, [8] [9] [10] [11] uraemia 3, 4 and ventricular hypertrophy [9] [10] [11] in patients with end stage renal disease (ESRD). On the other hand, DHD effects on mortality are less clear-cut.
Indeed, some studies reported improved survival associated with DHD, [12] [13] [14] [15] [16] while a recent work found that DHD was correlated with increased mortality compared with thrice-weekly HD. 17 However, the patients included in these studies had neither the same profile (in-centre or home dialyzed patients in different physical conditions and often from different countries) [12] [13] [14] [15] [16] [17] nor the same dialysis dose. Moreover, these works did not take into account all major comorbid conditions when assessing survival. [12] [13] [14] [15] [16] [17] In France, the few studies on DHD only investigated the biological effects of switching from HD to DHD. They found that DHD is well tolerated and improves the patients' nutritional status 18, 19 and quality of life. 19 However, the association between DHD and patients' survival has never been investigated in France. Compared with dialysis, renal transplantation is associated with longer survival. [20] [21] [22] However, organ availability is low and cannot cover the increasing demands for kidney transplantation. Daily haemodialysis could be the best choice of renal replacement treatment for patients on the renal transplant waiting list. To our knowledge, the association between DHD and access to renal transplantation has never been investigated. Therefore, the aim of this study was to assess the association between DHD and: (i) placement on the renal transplant waiting list; (ii) access to renal transplantation after being waitlisted; and (iii) patients' survival, in a large French cohort of patients receiving DHD compared with matched patients treated by standard HD three times/week.
MATERIALS AND METHODS

Study population
Since its establishment in 2002, the Renal Information and Epidemiological Network (REIN) registry intends to include all patients with ESRD who started renal replacement therapy (RRT) in France. 23 For the present study, all incident patients older than 18 years of age who received DHD for at least 30 days between 2003 and 2012 were selected. Short DHD was defined as ≥5 sessions of haemodialysis per week with a duration ≤5 h per session. Nocturnal DHD was not very developed in France before 2012. Moreover, short low-flow DHD was not available in France during the 2003-2012 period. Thus, only patients who received short DHD were included, whereas patients treated with alternative techniques, such as haemofiltration and haemodialfiltration, were excluded. A comparable group was selected among patients who received conventional HD (three sessions/week) for ≥30 days at the same nephrology facility and during the same period as the DHD group.
Data collection
Three categories of variables were extracted from REIN: (i) demographic data: sex and age; (ii) baseline bio-clinical data: smoking status (current/former smoker, never-smoker); albumin; haemoglobin; body mass index (BMI); comorbidities: diabetes, active malignancy, hepatic disease, chronic respiratory disease, cardiovascular disease (coronary artery disease, peripheral vascular disease, congestive heart failure, arrhythmia, aortic aneurism and cerebrovascular disease) and walking disability level (autonomous, partially dependent and totally dependent). Blood group (A, O, B and AB) and Panel Reactive Antibody (PRA) level were available for patients placed on the waiting list; and (iii) information on the medical follow-up: date of the first DHD or HD; emergency versus planned first dialysis session; starting RRT using a catheter; date of placement on the renal transplant waiting list; date of renal transplantation and date of death.
Statistical analysis
Matching procedures
Three patients on conventional HD were matched to one patient on DHD by dialysis facility, sex, age (AE2 years), year of dialysis initiation (AE2 years) and the logit of the propensity score that indicates the probability of receiving DHD compared with HD (AE0.05). The interval between the first dialysis and DHD initiation was also taken into account in the matching procedure. To calculate the propensity score, the logistic regression was performed using diabetes, active malignancy, chronic respiratory disease, cardiovascular diseases and walking disability as variables.
Multiple imputation method
Values were missing for 10 relevant covariates: albumin, haemoglobin and BMI (quantitative variables) as well as smoking status, diabetes, active malignancy, hepatic disease, chronic respiratory disease, cardiovascular disease and walking disability level (categorical variables). Estimate parameters were calculated using the Multiple Imputation by Chained Equations (MICE) procedure. 24 The process was repeated for all variables with missing values and to stabilize the results, the procedure was repeated for 10 cycles to produce a single imputed dataset. Finally, the whole procedure was iterated five times to obtain five imputed datasets. For each event of interest, a new cohort was modelled. Missing data in each dataset were handled by multiple imputations and for the three outcomes, three cohorts and three multiple imputations were produced.
Outcome analysis
Placement on the renal transplant waiting list. All patients younger than 80 years of age who started dialysis between 2003 and 2012 were included in the analysis. The outcome of interest was placement on the renal transplant waiting list before 31 December 2013 (endpoint). Patients placed on the renal waiting list before starting dialysis were considered as waitlisted at first dialysis. Death before waitlisting was considered as a competing event and was taken into account in the analysis using the competing risks regression model developed by Fine and Gray. 25 Cumulative incidence curves were also established.
analysis. Patients who received a renal transplant from a living donor were excluded from this analysis. The outcome of interest was renal transplantation before 31 December 2013. Analyses were performed using the Cox and the Fine and Gray models to take into account the mortality risk before renal transplantation. The patient's follow-up was assessed from the date of placement on the waiting list until the outcome (death, renal transplantation or end of follow-up).
Cumulative incidence curves of renal transplantation were also established. 
RESULTS
This study included 575 incident patients who underwent DHD for ≥30 days and 1696 incident patients on HD (3×/week) who were matched to the patients on DHD. The patients' selection procedure with exclusion criteria are provided in Figure 1 . The age (mean age: 60.3 AE 17.3 years for the DHD group; 60.5 AE 17.2 years for the 3×/week HD group) and several baseline characteristics were comparable in the two groups (presence of diabetes, hepatic disease and respiratory disease). However, the proportion of patients with cardiovascular disease, active malignancy or severe walking disabilities was higher in the DHD than in the 3×/week HD group (Table 1) .
Placement on the renal transplant waiting list
By the end of 2013, 774 patients (38% of the 2039 < 80-yearold patients, Table S1 ) had been placed on the waiting list (176 patients receiving DHD and 598 patients on HD) and 616/2039 (30.2%) had died without being waitlisted. The mean dialysis Daily haemodialysis in France duration before being placed on the waiting list was 1.5 AE 1.7 years for the DHD group and 1.4 AE 1.6 years for the HD group.
Unadjusted analysis (Fine & Gray model) showed that DHD (SHR = 0.83, 95%CI: 0.71-0.99), old age, all major comorbidities and emergency first dialysis were significantly associated with a lower probability of being waitlisted. In multivariate analysis, DHD was not independently associated with a reduced probability of being waitlisted, whereas all major comorbidities still restricted the access to the waiting list ( Table 2 , left panel). Similar results were obtained by using the Cox proportional model (HR) ( Table 2 , right panel). The probability of being waitlisted after 2 years of dialysis was approximately 25% for the DHD group and 30% for the HD group (Fig. 2) .
Access to renal transplantation of waitlisted patients
Waitlisted patients had fewer comorbidities compared with the whole cohorts. Moreover, the characteristics of patients placed on the waiting list at the date of waitlisting were not significantly different between groups, except for age and BMI (Table S2) .
Patients who received a renal transplant from a living donor were excluded from the analysis (n = 28/774, 3.6%). Overall, 435/746 (58.3%) patients underwent renal transplantation (n = 88 DHD, n = 347 HD) and 45/746 (6%) patients died while waiting for a renal transplant. In univariate analyses, patients receiving DHD (SHR = 0.74, 95%CI: 0.58-0.95) had a lower probability of being transplanted than patients on HD (Table 3, Overall the cumulative rate of renal transplantation after 2 years on the waiting list was approximately 25% and 35% for DHD and HD patients respectively (Fig. 3) .
Survival
The mean follow-up was 4.3 AE 2.7 years for patients receiving DHD and 4.7 AE 2.6 years for patients on HD. During this time, 275/575 (48%) patients on DHD and 552/1696 (32.5%) patients on HD died. Causes of death were various among dialyzed patients (Table 4) . Respiratory disease was the only cause of death significantly different between groups (3.6% for DHD patients vs 1.1% for HD 3×/week, P = 0.012).
In unadjusted analyses, DHD (HR = 1.6, 95%CI: 1.4-1.9; Table 5 ) as well as old age and all major comorbidities significantly increased the risk of death. Conversely, renal transplantation during the follow-up period was associated with a lower risk of death (HR = 0.20, 95%CI: 0.1-0.3). In the multivariate model, DHD (HR = 1.58, 95%CI: 1.4-1.8), old age and several comorbidities were still associated with a significantly higher risk of death. Renal transplantation during the follow-up (HR = 0.5, 95%CI: 0.3-0.8) remained associated with lower risk of death.
Overall, the risk of death after two years of dialysis treatment was approximately 20% for patients on DHD and 10% for patients on HD (Fig. 4) .
As our analysis included patients with missing data using a multiple imputation procedure, we also performed sensitivity analyses restricted to patients with complete data. The results (waitlisting, access to renal transplantation and survival) of the analyses for the group of patients with complete data were consistent with those obtained for all patients after the multiple imputation procedure (data not shown).
DISCUSSION
This first French study in which patients on short DHD were compared with matched patients on thrice-weekly HD shows that patients on DHD have a lower chance of access to renal transplantation after being waitlisted and a higher risk of death than patients on thrice-weekly HD. Conversely, this dialysis modality was not independently associated with a reduced access to the renal transplant waiting list.
In our study, unadjusted analysis indicated that the probability of being placed on the renal transplant waiting list was lower for patients receiving DHD. However, the association between DHD and waitlisting remained not statistically significant after the adjustment. This is the first study that analyzed the association between short DHD and access to renal transplant waiting list; therefore, we cannot compare our results with previous findings. Nevertheless, our data confirm the association between old age and restricted access to the renal transplant waiting list. 22, 26, 27 The probability of renal transplantation for waitlisted patients was lower in the DHD group than in the thrice-weekly HD group (SHR = 0.74, 95%CI: 0.57-0.96). In addition, having >2 cardiovascular diseases and PRA ≥80% were also associated with a lower chance of being transplanted, differently from the blood groups A and AB (compared with O). The negative effect of DHD on the probability of renal transplantation cannot be explained by the French rules on the allocation of organs from deceased donors. These rules take into account HLA matching, age adequacy between donor and recipient and time on the waiting list, but not the patient's clinical characteristics or dialysis modalities. A more in-depth study should be done to determine whether waitlisted patients who receive DHD refuse more often an organ proposition, or are more often on temporary inactive status for any other reason.
Like Suri et al., 17 we found that DHD was not associated with a survival benefit. These authors included only incentre dialyzed patients from the International Quotidian Dialysis Registry (IQDR), among whom there were many French patients (68%). They matched patients on DHD with patients who received 3×/week HD from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Unlike Suri et al., we took into account more comorbidities and matched patients on DHD with patients on HD (3 times/week) from the same dialysis facility. Other studies reported improved survival for patients who received DHD, 14, 15, 28, 29 but included only patients undergoing DHD at home. In some of these works, patients were compared with patients who received conventional in-centre HD. 14, 15 Moreover, patients dialyzed at home are generally healthier and younger than patients treated in-center. 16, 28, 29 This might explain the better survival observed among patients who receive DHD at home, 14, 16 as it has been recently discussed by Labriola et al., 30 Indeed, these authors highlighted the problem of selection bias and of indication bias in retrospective registry In our study, patients were mainly dialyzed in-centre (70%); however, we also included some patients dialyzed at home (6%) or in a satellite unit (24%). In the previous survival studies, beside the variety of dialysis environments, the populations under study were heterogeneous and patients receiving DHD were not always comparable with patients receiving conventional thrice-weekly HD. 12, 13, 16 Finally, in our study, and differently from others, [12] [13] [14] 28, 29 we selected patients who had been treated with dialysis for at least 30 days to avoid the inclusion of patients who received only a few dialysis sessions and/or of patients who died early. We hypothesize that DHD indications might be different in France than in other countries and this might explain the difference in mortality. The implementation of new short low-flow DHD at home is slowly progressing in France since 2012. Several studies showed that DHD has a positive effect on the patients' quality of life. [10] [11] [12] 18, 31 In the future, the development of new machines for short low-flow DHD at home might modify the negative association between DHD and survival. In the United States, low-flow short DHD at home has been in use for several years and the patients' biological parameters have been assessed in a few studies after initiation of such a treatment. 32, 33 Kraus et al., observed decreased blood pressure after switching from conventional HD to short DHD with low-flow machines. 33 In addition, such patients could reduce the antihypertensive drug intake and showed lower creatinine, albumin and haemoglobin values. Kohn et al., reported better phosphorous and urea removal associated with short DHD compared with conventional HD or peritoneal dialysis. The authors suggested that this dialysis modality improves toxin clearance and decreases morbidity and mortality. The strength of our study is the inclusion of a large unbiased population-based cohort that allowed us to analyze DHD association with access to renal transplant waiting list, renal transplantation and survival. Indeed, previous French studies on DHD included only small numbers of patients and focused on the quality of life or nutritional benefits. 18, 19 Thanks to the REIN registry, we could include all patients who received DHD for at least 30 days in France between 2003 and 2012 and we could select controls within the same facility to take into account the different medical practice profiles. Moreover, we included all major comorbidities and we used the Fine and Gray model to take into account competing risks. Our study has several limitations. This is an observational study and a hidden bias due to latent variables may remain despite the matching procedure. The medical reasons explaining the nephrologists' decisions to start or to switch to DHD were not recorded in the REIN registry. These missing variables could help to understand the lower survival of French patients on DHD. Moreover, data on the kt/V doses were often missing in the REIN registry and therefore, we could not determine whether patients on DHD received an appropriate dialysis dose per week. We included all major comorbidities present in the REIN registry in our study; however, it was very difficult to match patients for each comorbid condition. Therefore, we chose to use the propensity score measuring a global score of clinical risks Despite the matching procedure, the rates of cardiovascular disease, walking disabilities and active malignancy repartitions were different between the DHD and HD groups. In addition, our study focused on the effect of DHD performed for at least one month, but did not take into account the complete treatment trajectory of each patient.
Finally, as this study focused on patients on short DHD, our results cannot be generalized to patients on long, nocturnal home HD.
In conclusion, our study shows that French patients on short DHD have a lower chance of renal transplantation after being waitlisted and higher risk of death compared with matched patients on thrice-weekly HD. Even after taking into account all patients' characteristics, our study did not allow an understanding of why DHD is associated with higher risk of death in this population. Additional studies on the treatment trajectories of French patients who receive DHD might allow better assessment of the association between survival and dialysis history.
